239 related articles for article (PubMed ID: 26648136)
21. The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines.
Fragni M; Bonini SA; Bettinsoli P; Bodei S; Generali D; Bottini A; Spano PF; Memo M; Sigala S
Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):529-38. PubMed ID: 26905520
[TBL] [Abstract][Full Text] [Related]
22. Icaritin induces MC3T3-E1 subclone14 cell differentiation through estrogen receptor-mediated ERK1/2 and p38 signaling activation.
Wu Z; Ou L; Wang C; Yang L; Wang P; Liu H; Xiong Y; Sun K; Zhang R; Zhu X
Biomed Pharmacother; 2017 Oct; 94():1-9. PubMed ID: 28742995
[TBL] [Abstract][Full Text] [Related]
23. Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation.
Song L; Zhao J; Zhang X; Li H; Zhou Y
Eur J Pharmacol; 2013 Aug; 714(1-3):15-22. PubMed ID: 23764463
[TBL] [Abstract][Full Text] [Related]
24. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
25. Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2-Smad 1/5/8 signaling in human mesenchymal stem cells.
Kim BS; Kang HJ; Park JY; Lee J
Exp Mol Med; 2015 Jan; 47(1):e128. PubMed ID: 25572360
[TBL] [Abstract][Full Text] [Related]
26. Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway.
Hsu YL; Kuo PL
J Bone Miner Res; 2008 Jun; 23(6):949-60. PubMed ID: 18269307
[TBL] [Abstract][Full Text] [Related]
27. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
28. Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation.
Ebert R; Zeck S; Krug R; Meissner-Weigl J; Schneider D; Seefried L; Eulert J; Jakob F
Bone; 2009 May; 44(5):858-64. PubMed ID: 19442618
[TBL] [Abstract][Full Text] [Related]
29. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
[TBL] [Abstract][Full Text] [Related]
30. The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches.
Soki FN; Li X; Berry J; Koh A; Sinder BP; Qian X; Kozloff KM; Taichman RS; McCauley LK
J Cell Biochem; 2013 Jan; 114(1):67-78. PubMed ID: 22833499
[TBL] [Abstract][Full Text] [Related]
31. In vitro synergistic effects of zoledronic acid and calcium on viability of human epithelial cells.
Arai N; Inoue S; Tomihara K; Tsuno H; Noguchi M
Oral Dis; 2013 Mar; 19(2):200-5. PubMed ID: 22891943
[TBL] [Abstract][Full Text] [Related]
32. Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw.
Manzano-Moreno FJ; Ramos-Torrecillas J; Melguizo-Rodríguez L; Illescas-Montes R; Ruiz C; García-Martínez O
Int J Med Sci; 2018; 15(4):359-367. PubMed ID: 29511371
[TBL] [Abstract][Full Text] [Related]
33. FGF18 inhibits MC3T3‑E1 cell osteogenic differentiation via the ERK signaling pathway.
Zhai F; Song N; Ma J; Gong W; Tian H; Li X; Jiang C; Wang H
Mol Med Rep; 2017 Oct; 16(4):4127-4132. PubMed ID: 28765932
[TBL] [Abstract][Full Text] [Related]
34. The roles of extracellular signal-regulated kinase 1/2 pathway in regulating osteogenic differentiation of murine preosteoblasts MC3T3-E1 cells on roughened titanium surfaces.
Zhuang LF; Jiang HH; Qiao SC; Appert C; Si MS; Gu YX; Lai HC
J Biomed Mater Res A; 2012 Jan; 100(1):125-33. PubMed ID: 21997903
[TBL] [Abstract][Full Text] [Related]
35. Role of mitogen-activated protein kinase (MAPK) in troglitazone-induced osteoblastic cell death.
Jung JY; Yoo CI; Kim HT; Kwon CH; Park JY; Kim YK
Toxicology; 2007 May; 234(1-2):73-82. PubMed ID: 17363128
[TBL] [Abstract][Full Text] [Related]
36. Krüppel-like factors KLF2 and 6 and Ki-67 are direct targets of zoledronic acid in MCF-7 cells.
Ebert R; Zeck S; Meissner-Weigl J; Klotz B; Rachner TD; Benad P; Klein-Hitpass L; Rudert M; Hofbauer LC; Jakob F
Bone; 2012 Mar; 50(3):723-32. PubMed ID: 22166808
[TBL] [Abstract][Full Text] [Related]
37. [Study on the effects of zoledronic-acid-loaded collagen membrane on bone metabolism cells].
Meng YH; Peng Y; Liu D; Chen Y; Wang H; Liang X
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Feb; 46(2):107-11. PubMed ID: 21426781
[TBL] [Abstract][Full Text] [Related]
38. Possible involvement of p38 MAP kinase in prostaglandin E1-induced ALP activity in osteoblast-like cells.
Kakita A; Suzuki A; Ono Y; Miura Y; Itoh M; Oiso Y
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):469-74. PubMed ID: 15062850
[TBL] [Abstract][Full Text] [Related]
39. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice.
Schindeler A; Ramachandran M; Godfrey C; Morse A; McDonald M; Mikulec K; Little DG
J Orthop Res; 2008 Jan; 26(1):65-74. PubMed ID: 17787010
[TBL] [Abstract][Full Text] [Related]
40. Zoledronic acid induces micronuclei formation, mitochondrial-mediated apoptosis and cytostasis in kidney cells.
Singireesu SSNR; Mondal SK; Yerramsetty S; Misra S
Life Sci; 2018 Jun; 203():305-314. PubMed ID: 29729261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
